ReShape Lifesciences

homesitemapcontact us

   search

 

   
   
   
   
 

Overview

 
 

Events and Presentations

 
 

Press Releases

 
 

SEC Filings

 
 

Stock Information

 
 

Analyst Coverage

 

Management

 
 

Corporate Governance

 
 

Investor FAQs

 
 

Annual Reports, Proxy Statements, and Supplemental Financial Info

 
 

Email Alerts

 

For investor inquiries, please contact:

Investor Contact:
Scott Youngstrom
651-634-3011
ir@enteromedics.com

 

Analyst Coverage



Firm  
Ladenburg Thalmann & Co. Inc.   Jeffrey Cohen
Northland Securities   Suraj Kalia

ReShape Lifesciences is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding ReShape Lifesciences' performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ReShape Lifesciences or its management. ReShape Lifesciences does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.